AN ACT CONCERNING THE OFFICE OF HEALTH STRATEGY'S RECOMMENDATIONS REGARDING 340B PROGRAM TRANSPARENCY.
To require entities authorized to participate in the federal 340B Drug Pricing Program to report to the Health Systems Planning Unit of the Office of Health Strategy certain information regarding the program, including (1) aggregated acquisition costs, (2) aggregated payment information, (3) the number of claims for prescription drugs under the program, and (4) if the entity is a hospital, the national drug code number for the fifty most frequently dispensed prescription drugs by the hospital under the program.
Introduced by:
Public Health Committee| New today | 2-4 days old | 5 days & older |
| Text of Bill | |
| File No. 382 [doc] | |
| PH Joint Favorable Substitute [doc] | |
| Raised Bill [doc] |
| Uncalled Amendments | |
| Senate LCO Amendment #4886 (R) [doc] |
| Committee Actions | |
| PH Joint Fav. Rpt | |
| PH Vote Tally Sheet (Joint Favorable Substitute) |
| Fiscal Notes | |
| Fiscal Note for Amendment LCO 4886 (See Fiscal Note Details) | |
| Fiscal Note For File Copy 382 |
| Bill Analyses | |
| Bill Analysis For File Copy 382 |
Add Notes to SB-241
Go To My Bills
This bill is in My Bills.
Do you wish to go to My Bills?
Co-sponsors for Amendment LCO:
Bill History
| Date | Action Taken | ||
|---|---|---|---|
| 4/10/2024 | (LCO) | File Number 382 | |
| 4/10/2024 | Senate Calendar Number 244 | ||
| 4/10/2024 | Favorable Report, Tabled for the Calendar, Senate | ||
| 4/10/2024 | (LCO) | Reported Out of Legislative Commissioners' Office | |
| 4/4/2024 | (LCO) | Referred to Office of Legislative Research and Office of Fiscal Analysis 04/09/24 5:00 PM | |
| 3/25/2024 | (LCO) | Filed with Legislative Commissioners' Office | |
| 3/22/2024 | (PH) | Joint Favorable Substitute | |
| 2/26/2024 | Public Hearing 03/01 | ||
| 2/22/2024 | Referred to Joint Committee on Public Health |
NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.
